Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,300
Closed -$52.3K 9323
2023
Q4
$52.3K Buy
+12,300
New +$66.7K ﹤0.01% 8769
2023
Q3
Sell
-51,400
Closed -$538K 8739
2023
Q2
$538K Buy
51,400
+28,300
+123% +$253K ﹤0.01% 6203
2023
Q1
$161K Buy
+23,100
New +$201K ﹤0.01% 7971
2022
Q3
Sell
-18,300
Closed -$246K 9805
2022
Q2
$246K Sell
18,300
-1,600
-8% -$26.5K ﹤0.01% 7898
2022
Q1
$387K Sell
19,900
-32,500
-62% -$649K ﹤0.01% 7938
2021
Q4
$1.8M Sell
52,400
-35,400
-40% -$1.42M ﹤0.01% 4681
2021
Q3
$4.81M Sell
87,800
-296,100
-77% -$17.8M ﹤0.01% 2802
2021
Q2
$28.2M Buy
383,900
+296,500
+339% +$29.6M 0.01% 847
2021
Q1
$7.99M Buy
87,400
+8,700
+11% +$844K ﹤0.01% 1795
2020
Q4
$6.38M Buy
78,700
+67,000
+573% +$5.13M ﹤0.01% 1836
2020
Q3
$545K Buy
+11,700
New +$653K ﹤0.01% 5018

Jane Street's CVAC Position: Q1 2026 in Review

Jane Street sold out of CureVac (CVAC) in Q1 2026, closing a stake of 203,665 shares — an estimated $866K sold.

Jane Street first reported a position in CVAC in Q3 2020 and held it in 18 quarters. The position peaked at $5.09M in Q4 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Jane Street reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 203,665 CureVac shares in Q1 2026, an estimated $866K.
  • Jane Street first reported a position in CureVac in Q3 2020 and held it in 18 quarters.
  • Jane Street's CureVac position peaked at $5.09M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.